Author

C. Opitz

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Assay:DNA methylation· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Assay:metabolomics· 1

Frequent Co-Authors

A. Goncalves· 1 shared A. Hofer· 1 shared A. Marciniak-Czochra· 1 shared A. Martin-Villalba· 1 shared A. Sadik· 1 shared A. Tang· 1 shared A.-S. Egger· 1 shared C. R. Wirtz· 1 shared

Activity by Year

2023-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Goncalves

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Automated liquid handling extraction and rapid quantification of underivatized amino acids and tryptophan metabolites from human serum and plasma using dual-column U(H)PLC-MRM-MS and its application to prostate cancer study.

T. Kipura, M. Hotze, A. Hofer, A.-S. Egger, L. E. Timpen, C. Opitz, P. Townsend, L. Gethings, K. Thedieck, M. Kwiatkowski

The paper develops an automated workflow and dual-column U(H)PLC-MRM-MS method to rapidly quantify amino acids and tryptophan metabolites in human serum and plasma, applied to a prostate cancer study to identify biomarkers.

Metabolites · Jun 30, 2024Peer-reviewedBiochemistry

Cross-species comparison reveals therapeutic vulnerabilities halting glioblastoma progression

L. C. Foerster, O. Kaya, V. Wust, D.-P. Danciu, M. Bekavac, K. C. Ziegler, V. Akcay, N. Stinchcombe, A. Tang, J. Tang, J. Brunken, N. Gesteira Perez, X. Ma, A. Sadik, C. Opitz, , A. Martin-Villalba

This study identifies SFRP1 as a therapeutic target for glioblastoma by revealing its role in reprogramming tumor methylomes and improving survival in mouse models.

bioRxiv · Sep 15, 2023Cancer Biology